Related Experiment Video
Updated: Sep 16, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Rhodotorula species fungemia: a threat to the immunocompromised host
Maria Anatoliotaki1, Elpis Mantadakis, Emmanuel Galanakis
1The University of Crete, Division of Medicine, Heraklion, Crete, Greece.
Abstract:
Members of the genus Rhodotorula, family Cryptococcaceae, are common airborne fungi showing remarkable ubiquity. In the recent past they were considered nonvirulent saprophytes. However, during the last two decades they have emerged as opportunistic pathogens in immunocompromised patients. A review of the English literature covering the period 1960-2001 disclosed 47 reported cases of Rhodotorula spp fungemia. The great majority of these infections has been reported after 1990, were catheter-related, and diagnosed in patients with cancer. The treatment of Rhodotorula fungemia remains controversial. Resolution of coexistent neutropenia is essential for recovery. Removal of the central venous catheter is usually sufficient and treatment with systenic antifungals may not be required. If catheter removal is undesirable or impossible or when the infection persists, treatment with amphotericin B is the treatment of choice. Rhodotorula is a fungus with a low virulence and fatality rate. Hence, most patients with Rhodotorula fungemia reported in the literature survived with or without administration of antifungal agents.
Insights
Rhodotorula fungi, once considered harmless, are now opportunistic pathogens in immunocompromised individuals. Most Rhodotorula fungemia cases are catheter-related in cancer patients, often resolving with catheter removal and supportive care.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Rhodotorula are ubiquitous airborne fungi, previously classified as non-pathogenic saprophytes.
- Recent decades show an emergence of Rhodotorula as opportunistic pathogens, particularly in immunocompromised populations.
- This shift necessitates a re-evaluation of their clinical significance and management.
Purpose of the Study:
- To review and analyze reported cases of Rhodotorula species fungemia.
- To understand the epidemiological trends and clinical characteristics of these infections.
- To evaluate current treatment strategies and outcomes for Rhodotorula fungemia.
Main Methods:
- Comprehensive literature search of English-language publications from 1960 to 2001.
- Inclusion of reported cases of Rhodotorula species fungemia.
- Analysis of patient demographics, infection sources, clinical features, and treatment outcomes.
Main Results:
- A total of 47 cases of Rhodotorula spp fungemia were identified between 1960 and 2001.
- The majority of reported infections occurred after 1990, were associated with central venous catheters, and diagnosed in cancer patients.
- Most patients survived, with recovery often linked to resolution of neutropenia and central venous catheter removal.
Conclusions:
- Rhodotorula fungemia is an emerging opportunistic infection, primarily affecting immunocompromised patients, especially those with cancer and central venous catheters.
- Central venous catheter removal is a critical intervention, and systemic antifungal therapy may not always be necessary.
- Amphotericin B is the preferred treatment if catheter removal is not feasible or infection persists, though Rhodotorula generally exhibits low virulence and fatality rates.
More Related Videos
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Rocky Mountain Spotted Fever
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis
Candidiasis

